57
Participants
Start Date
June 30, 2004
Primary Completion Date
June 30, 2006
Study Completion Date
June 30, 2006
ridaforolimus
AP23573 12.5 mg IV as monotherapy once daily for 5 days, every 2 weeks
New York Presbyterian Hospital, Weill College of Cornell University, New York
Jeane's Hospital of TUHS, Philadelphia
Morris Cancer Center - Duke University Medical Center, Adult Bone Marrow Transplant Clinic, Durham
Gabrail Cancer Center, Canton
University of Chicago Hospitals, Section of Hematology/Oncology, Chicago
Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, St Louis
MD Anderson Cancer Center, Houston
The Cancer Institute of New Jersey, New Brunswick
Collaborators (1)
Ariad Pharmaceuticals
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY